Gilead Sciences target price raised to $195 from $175 by UBS
GILD•UBS raised its target price for Gilead Sciences to $195 from $175.
Related News
Nasdaq pauses Purple trading for volatility at 9:47 a.m.
PRPL•
Nasdaq tumbles at open as Amazon, Intel add to AI spending woes
QQQ•
Sanofi signals appetite for larger deals, lifts 2026 growth targets under CEO Garijo
SNY•
IBX partners with Sunlife, Symetra to expand employee benefits offerings
SLF•
Enterprises invest in ESG data modernization amid shifting regulations, ISG says
III•